Precisely control cell quality and reshape healthy life
2000㎡"Biomedical Space", exploring more possibilities for the future
While there is life, there is technology progressing
In-depth research on translational applications of stem cell, immune cell and exosome technologies
SunGene&Cell Biotechnology
Committed to building a safe, accurate and systematic transformation center of bioscience innovation services
Founded in 2020 with a total investment of 150 million RMB and located in West China Health Valley, Chengdu, Sichuan, SunGene&Cell is a biotechnology innovation enterprise dominated by cell technology with a core focus on clinical R&D and regenerative health.
Supported by a powerful "biomedical space" and the introduced high-level talents with master's and doctoral degrees from the Regenerative Medicine Research Center of West China Hospital, SunGene&Cell is deeply engaged in the translational application research of stem cell, immune cell and exosome technologies, and committed to building a safe, accurate and systematic transformation center of bioscience innovation services, with the corporate philosophy of "integrate innovation, win-win cooperation”.
Adhering to the concept of "taking talents as the foundation"，SunGene&Cell with the professor of West China Hospital of Sichuan University as the guiding expert and the former doctoral and master's team of West China Hospital of Sichuan University as the leader, has built an innovation fleet and is committed to exploring the path of creating health and benefiting mankind in the stem cell industry.
Equipped with world-class and FDA-certified cell therapy drug testing equipment.
Relying on Cell's "Biomedical Space", it undertakes the construction and operation of life sciences, and the management of cell preparation.
From the cell to the universe, see the endless world, from the cell to the living Kisel, see the infinite possibility of life.
Limited time recruitment of city partners
Seize the Trillion level Industrial Track of Bioeconomy
Dividend Explosion | Unlimited Money Path
Limited quota to take the lead and seize wealth
Franchise hotline: 15680057241
Recently, the Department of Science and Technology of Sichuan Province announced the list of the twelfth batch of technology-based SMEs in 2022, and SunGene&Cell has successfully entered Sichuan technology-based SMEs!
Recently, the Department of Science and Technology of Sichuan Province announced the list of the twelfth batch of technology-based SMEs in 2022, and SunGene&Cell has successfully entered Sichuan technology-based SMEs!
We will accelerate the transformation and clinical application of relevant technology products, and promote the formation of a new model of regenerative medicine and precision medicine treatment......
Due to the broad application prospect of cell therapy, the global cell industry has developed rapidly and the market scale has gradually expanded. In recent years, stem cell research and application have become an important indicator to measure the development of life science and medicine in a country.....
川公网安备 51010702003112号